Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Title||Journal of Translational Autoimmunity|
|Abbreviation||J. Transl. Autoimmun.|
|Subject Area, Categories, Scope||Immunology (Q3); Immunology and Allergy (Q3)|
|SCImago Journal Rank (SJR)||0.796|
Journal of Translational Autoimmunity is a journal covering the technologies/fields/categories related to Immunology (Q3); Immunology and Allergy (Q3). It is published by Elsevier BV. The overall rank of Journal of Translational Autoimmunity is 5785. According to SCImago Journal Rank (SJR), this journal is ranked 0.796. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 9. The best quartile for this journal is Q3.
The ISSN of Journal of Translational Autoimmunity journal is 25899090. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Translational Autoimmunity is cited by a total of 241 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Journal of Translational Autoimmunity is 3.77, which is computed in 2022 as per its definition. Journal of Translational Autoimmunity IS is increased by a factor of 2.77 and approximate percentage change is 277% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Journal of Translational Autoimmunity is 3.77. If the same upward trend persists, impact score may rise in 2022 as well.
|Year||Impact Score (IS)|
Journal of Translational Autoimmunity has an h-index of 9. It means 9 articles of this journal have more than 9 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Translational Autoimmunity is 25899090. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Translational Autoimmunity is 5785. According to SCImago Journal Rank (SJR), this journal is ranked 0.796. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Journal of Translational Autoimmunity is published by Elsevier BV. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2019-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Translational Autoimmunity is J. Transl. Autoimmun.. This abbreviation ('J. Transl. Autoimmun.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Immunology (Q3); Immunology and Allergy (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Behavioral Research in Accounting||journal||2897||American Accounting Association||28||2.69|
|Journal of Knee Surgery||journal||6559||Thieme Medical Publishers||64||2.12|
|Written Language and Literacy||journal||19129||John Benjamins Publishing Company||25||0.28|
|Journal of Clinical Oncology||journal||79||American Society of Clinical Oncology||574||15.37|
|Praticien en Anesthesie Reanimation||journal||24328||Elsevier Masson s.r.l.||5||0.08|
|QJM - Monthly Journal of the Association of Physicians||journal||6221||Oxford University Press||123||2.64|
|Urology Times||journal||26464||Advanstar Communications Inc.||2||0.01|
|Ars Combinatoria||journal||17659||Charles Babbage Research Centre||37||0.12|
|Global Food Security||journal||1070||Elsevier||56||9.02|
|Food and Drug Law Journal||journal||10286||Food and Drug Law Institute||22||0.00|